85
Participants
Start Date
October 31, 2002
Primary Completion Date
September 30, 2006
Study Completion Date
September 30, 2006
Celecoxib
University of Michigan Comprehensive Cancer Center, Ann Arbor
MD Anderson Cancer Center, Houston
Hartford Hospital, Hartford
Massachusetts General Hospital, Boston
Dana-Farber Cancer Institute, Boston
Faulkner Hospital, Boston
Beth Israel Deaconess Medical Center, Boston
Emerson Hospital, Concord
Lowell General Hospital, Lowell
Collaborators (1)
Pfizer
INDUSTRY
Beth Israel Deaconess Medical Center
OTHER
Emerson Hospital, Concord, MA
OTHER
Brigham and Women's Hospital
OTHER
Hartford Hospital
OTHER
Lowell General Hospital
OTHER
Massachusetts General Hospital
OTHER
M.D. Anderson Cancer Center
OTHER
University of Michigan Rogel Cancer Center
OTHER
Dana-Farber Cancer Institute
OTHER